Please assess the completion status of the following clinical trial:

Trial Title: Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Infrarenal AAA \> or equal to 4.5 cm in diameter~* Proximal infrarenal aortic neck length \> or equal 15mm~* Anatomy meets 31mm EXCLUDER specification criteria~* Access vessel able to receive 20 Fr. introducer sheath~* Life expectancy \>2 years~* Surgical candidate~* ASA Class I, II, III, or IV~* NYHA Class I, II, III~* 21 years of age or older~* Male or infertile female~* Ability to comply with protocol requirements including follow-up~* Signed Informed Consent Form~Exclusion Criteria:~* Mycotic or ruptured aneurysm~* Participating in another investigational device or drug study within 1 year~* Documented history of drug abuse within 6 months~* Coexisting thoracic aortic aneurysm (50% larger than proximal aorta)~* Myocardial infarction or cerebral vascular accident within 6 weeks~* Pulmonary insufficiency requiring chronic home oxygen therapy or inability to ambulate due to pulmonary function~* Renal insufficiency (Creatinine \> 2.5 mg/dL) without dialysis~* Iliac anatomy that would require occlusion of both internal iliac arteries~* Planned occlusion or reimplantation of significant mesenteric or renal arteries~* Planned concomitant surgical procedure or previous major surgery within 30 days~* Previous prosthesis placement in the same position of the aorta or iliac arteries~* Degenerative connective tissue disease, e.g., Marfans and Ehlers Danlos Syndrome~* Proximal neck angulation \> 60 degrees~* Presence of significant thrombus at arterial implantation sites

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 31 mm GORE EXCLUDER® Test Subjects (Type: EXPERIMENTAL): GORE EXCLUDER® AAA Endoprosthesis - 31 mm device implanted for the primary treatment of infrarenal abdominal aortic aneurysms (AAA)

Based on this trial design, predict the completion outcome and termination type (if applicable).